Jeon Yung Jin, Joo Yeon-Hee, Cho Hyun-Jin, Kim Sang-Wook, Park Bumjung, Choi Hyo Geun
Department of Otorhinolaryngology, Gyeongsang National University Hospital, Jinju, Republic of Korea.
Institute of Health Sciences, Gyeongsang National University, Jinju, Republic of Korea.
Laryngoscope. 2023 May;133(5):1044-1051. doi: 10.1002/lary.30162. Epub 2022 May 19.
Chronic rhinosinusitis (CRS) is one of the most common chronic inflammatory diseases. The effect of chronic inflammation caused by CRS on the occurrence of various cancers has not been thoroughly evaluated. This study aimed to investigate the increased incidences of 10 types of cancers among CRS patients with/without nasal polyps (NP) using a national population-based database from the Korean Health Insurance Review and Assessment Service.
A case-control cohort study.
We compared the prevalence of various comorbidities between CRS and control participants from a national cohort dataset of the Korean Health Insurance Review and Assessment Service.
CRS participants (n = 6,919) and non-CRS (n = 27,676) participants were selected from among the 514,866 participants from 2002 to 2015. A stratified Cox proportional hazards model was utilized to assess the hazard ratio (HR) of CRS for 10 types of cancers.
A stratified Cox proportional hazard model demonstrated that the adjusted HR for hematologic malignancy was significantly higher in the CRS patients than in the controls regardless of the presence of NP (2.90 for total CRS; 2.15 for CRS with NP; 4.48 for CRS without NP). The HR for thyroid cancer was significantly higher in the CRS patients without NP but not in those with NP (1.50 for total CRS; 1.78 for CRS without NP).
This study showed that CRS participants had a significantly higher prevalence of hematologic malignancy and thyroid cancer.
4 Laryngoscope, 133:1044-1051, 2023.
慢性鼻-鼻窦炎(CRS)是最常见的慢性炎症性疾病之一。CRS引起的慢性炎症对各种癌症发生的影响尚未得到充分评估。本研究旨在利用韩国健康保险审查与评估服务中心基于全国人口的数据库,调查有/无鼻息肉(NP)的CRS患者中10种癌症的发病率增加情况。
病例对照队列研究。
我们比较了韩国健康保险审查与评估服务中心全国队列数据集中CRS参与者与对照参与者之间各种合并症的患病率。
从2002年至2015年的514,866名参与者中选取CRS参与者(n = 6,919)和非CRS参与者(n = 27,676)。采用分层Cox比例风险模型评估CRS患10种癌症的风险比(HR)。
分层Cox比例风险模型显示,无论有无NP,CRS患者血液系统恶性肿瘤的校正HR均显著高于对照组(CRS总体为2.90;有NP的CRS为2.15;无NP的CRS为4.48)。无NP的CRS患者甲状腺癌的HR显著更高,但有NP的患者则不然(CRS总体为1.50;无NP的CRS为1.78)。
本研究表明,CRS参与者血液系统恶性肿瘤和甲状腺癌的患病率显著更高。
4 喉镜,133:1044 - 1051,2023年。